Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

PDA helps members secure around £196,000 through tribunal claims

The Pharmacists’ Defence Association (PDA) has helped its members to secure around £196,000 last year from employers who treated pharmacists badly or breached their rights in some way.

The association strives to help members to resolve workplace disputes quickly, locally, and amicably, however some cases need escalation into the legal system, it said.


It helps pharmacists to understand and exercise their rights in case unfair treatment occurs to them.

Though no employee expects to be treated badly, this is the reality for some pharmacists, the PDA stated.

Encouraging all employed and locum pharmacists to become a member, the association said it could offer better help to those who join the PDA.

More For You

Students from retail sector using bursary aid for postgraduate education

The charity has given £28 million worth of financial aid to postgraduate students.

Bursary applications open for pharmacy students

A leading charity that provides financial aid for the families of those working in the pharmacy, convenience and grocery sector, has announced postgraduate bursary applications open for 2025/2026.

The Leverhulme Trade Charities Trust (LTCT) bursary scheme is open to students on postgraduate courses, whose parent, carer, spouse is employed in an eligible profession, such as convenience retailer, supermarket store worker, or pharmacy technician.

Keep ReadingShow less
The NHS has changed payment structure for consultations

The NHS has changed payment structure for consultations

Maximising new medicine services can be a game changer for pharmacists

Adele Curran, chief operations officer at RWA Pharmacy Ltd, looks at the changes to NMS and the financial opportunities they offer for Community Pharmacies

English pharmacies have been delivering new medicine services (NMS) since October 2011. They have successfully increased the effective use of medicines across their communities and also increased their revenue through the claiming structure.

Keep ReadingShow less
Camizestrant Cuts Breast Cancer Progression by 50% – New Hope

There was a 56 per cent reduction in the risk of disease progression or death

Pic credit: iStock

Blood test-guided treatment with AstraZeneca pill cuts breast cancer progression risk

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard therapies cut the risk of disease progression or death by half, a finding that could be practice changing, experts said on Sunday.

The results, presented at the American Society of Clinical Oncology meeting in Chicago, mark the first use of a blood test called a liquid biopsy to indicate the need for a change in treatment in women with a common form of breast cancer, even before tumor growth can be detected on imaging.

Keep ReadingShow less
medicine stock shortage

Creon is used in pancreatic cancer patients to help digest food

Pic credit: iStock

Patients lives being put at risk due to ‘worst stock shortage’, warns pharmacists

Cancer patients are skipping meals in order to ration a vital medicine that has been difficult to get hold of due to ongoing shortages.

Pharmacists have warned of the struggles they are facing to source Creon - a pancreatic enzyme replacement therapy (PERT), which helps people living with conditions such as cystic fibrosis, pancreatitis, and pancreatic cancer to digest food.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

Acute sore throats had the most consultations

Pic credit: istock

Pharmacy First has already seen over five million patients

The Pharmacy First scheme has helped over five million patients with minor illnesses, according to NHS England.

Around 2.4 million people received help without booking an appointment at their local pharmacy for seven common conditions including sore throat, earache or shingles.

Keep ReadingShow less